A detailed history of Nicolet Advisory Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Nicolet Advisory Services, LLC holds 3,497 shares of LLY stock, worth $2.78 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
3,497
Previous 3,230 8.27%
Holding current value
$2.78 Million
Previous $2.92 Million 5.95%
% of portfolio
0.29%
Previous 0.29%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $206,161 - $256,325
267 Added 8.27%
3,497 $3.1 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $49,291 - $61,814
-68 Reduced 2.06%
3,230 $2.92 Million
Q1 2024

May 09, 2024

BUY
$592.2 - $792.28 $208,454 - $278,882
352 Added 11.95%
3,298 $2.57 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $47,267 - $55,721
90 Added 3.15%
2,946 $1.72 Million
Q3 2023

Nov 07, 2023

BUY
$434.7 - $599.3 $138,234 - $190,577
318 Added 12.53%
2,856 $1.53 Million
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $38,230 - $51,118
109 Added 4.49%
2,538 $1.19 Million
Q1 2023

May 09, 2023

BUY
$310.63 - $364.82 $155,625 - $182,774
501 Added 25.99%
2,429 $834,000
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $178,138 - $207,567
554 Added 40.32%
1,928 $705,000
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $117,999 - $134,472
-398 Reduced 22.46%
1,374 $445,000
Q2 2022

Aug 08, 2022

SELL
$278.73 - $327.27 $37,628 - $44,181
-135 Reduced 7.08%
1,772 $581,000
Q1 2022

May 10, 2022

SELL
$234.69 - $291.66 $17,601 - $21,874
-75 Reduced 3.78%
1,907 $594,000
Q4 2021

Feb 08, 2022

SELL
$224.85 - $279.04 $162,566 - $201,745
-723 Reduced 26.73%
1,982 $548,000
Q3 2021

Nov 16, 2021

BUY
$221.6 - $272.71 $101,492 - $124,901
458 Added 20.38%
2,705 $624,000
Q2 2021

Aug 11, 2021

SELL
$180.55 - $233.54 $153,828 - $198,976
-852 Reduced 27.49%
2,247 $516,000
Q1 2021

May 03, 2021

SELL
$164.32 - $212.72 $25,798 - $33,397
-157 Reduced 4.82%
3,099 $579,000
Q4 2020

Feb 09, 2021

BUY
$130.46 - $172.63 $7,436 - $9,839
57 Added 1.78%
3,256 $550,000
Q3 2020

Oct 27, 2020

SELL
$146.22 - $169.13 $34,946 - $40,422
-239 Reduced 6.95%
3,199 $473,000
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $38,334 - $46,134
-281 Reduced 7.56%
3,438 $565,000
Q1 2020

Apr 21, 2020

BUY
$119.05 - $147.35 $66,787 - $82,663
561 Added 17.76%
3,719 $516,000
Q4 2019

Jan 23, 2020

BUY
$106.92 - $132.43 $9,195 - $11,388
86 Added 2.8%
3,158 $415,000
Q3 2019

Oct 22, 2019

BUY
$106.79 - $116.16 $30,221 - $32,873
283 Added 10.15%
3,072 $344,000
Q2 2019

Jul 26, 2019

BUY
$110.79 - $129.32 $221 - $258
2 Added 0.07%
2,789 $309,000
Q1 2019

May 10, 2019

BUY
$111.31 - $131.02 $310,220 - $365,152
2,787 New
2,787 $362,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Nicolet Advisory Services, LLC Portfolio

Follow Nicolet Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicolet Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nicolet Advisory Services, LLC with notifications on news.